Alamar Biosciences, Inc.·3

Apr 16, 9:23 PM ET

Qiming Venture Partners VI, L.P. 3

3 · Alamar Biosciences, Inc. · Filed Apr 16, 2026

Insider Transaction Report

Form 3
Period: 2026-04-16
Holdings
  • Series A-3 Preferred Stock

    [F1][F2]
    (indirect: See footnote)
    Class B Common Stock (71,268 underlying)
  • Series A-3 Preferred Stock

    [F1][F3]
    (indirect: See footnote)
    Class B Common Stock (2,648,607 underlying)
  • Series A-4 Preferred Stock

    [F1][F2]
    (indirect: See footnote)
    Class B Common Stock (63,864 underlying)
  • Series A-4 Preferred Stock

    [F1][F3]
    (indirect: See footnote)
    Class B Common Stock (2,373,437 underlying)
  • Series B Preferred Stock

    [F4][F2]
    (indirect: See footnote)
    Class B Common Stock (50,031 underlying)
  • Series B Preferred Stock

    [F4][F3]
    (indirect: See footnote)
    Class B Common Stock (1,859,366 underlying)
  • Series C Preferred Stock

    [F1][F5]
    (indirect: See footnote)
    Class B Common Stock (1,605,645 underlying)
  • Series C Preferred Stock

    [F1][F6]
    (indirect: See footnote)
    lass B Common Stock (1,922,329 underlying)
Footnotes (6)
  • [F1]Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock is convertible into 0.4136 share of Class B Common Stock, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock have no expiration date.
  • [F2]These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  • [F3]These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  • [F4]Each share of Series B Preferred Stock is convertible into 0.4403 share of Class B Common Stock, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The Series B Preferred Stock has no expiration date.
  • [F5]These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
  • [F6]These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

Documents

1 file
  • 3
    form3-04172026_010412.xmlPrimary